Lung bioreactor
AssigneeThe General Hospital Corporation
InventorHarald C. Ott
Life of this patent
Estimating the term…
Abstract
Presented is an airway organ bioreactor apparatus, and methods of use thereof, as well as bioartificial airway organs produced using the methods, and methods of treating subjects using the bioartificial airway organs. The bioreactor comprises: an organ chamber: an ingres line connecting the organ chamber and a reservoir system and comprising an arterial line, a venous line and a tracheal line; an egress line connecting the chamber and the reservoir system, pumps in ingress and egress lines; a controller to control fluid exchange; a chamber pressure sensor connected to the organ chamber.
Claims8
A method of providing a wet-matured lung organ, the method comprising:
- providing:
- (i) an organ chamber configured to connect to an arterial line, to a venous line, and to a tracheal line;
- (ii) a chamber pressure sensor connected to the organ chamber, the chamber pressure sensor configured to record and transmit a pressure reading at the organ chamber to a controller;
- (iii) a lung tissue matrix including an airway and substantial vasculature;
- and
- (iv) a media reservoir system;
- connecting the airway to the media reservoir system via the tracheal line;
- connecting the lung tissue matrix to the arterial line and to the venous line;
- connecting the organ chamber to the media reservoir system via an ingress line and an egress line, wherein the ingress line comprises an ingress pump and wherein the egress line comprises a bidirectional egress pump;
- seeding the lung tissue matrix with cells over at least one of the following:
- the arterial line, the venous line, or the tracheal line;
- providing the lung tissue matrix with wet ventilation for a time sufficient for a first desired degree of organ maturation to occur to produce a wet-matured organ;
- and
- maintaining a substantially constant fluid level in the organ chamber during negative pressure wet ventilation, wherein maintaining the substantially constant fluid level comprises:
- monitoring pressure in the organ chamber using the chamber pressure sensor and the controller;
- and
- correcting for fluid shifts through the lung tissue matrix into the organ chamber by adjusting direction and duration of the bidirectional egress pump.
A method comprising:
- providing:
- (i) a lung tissue matrix including an airway and substantial vasculature;
- (ii) an organ chamber configured to hold the lung tissue matrix, and
- (iii) a media reservoir system;
- connecting the organ chamber to the media reservoir system via an ingress line and an egress line, wherein the ingress line comprises an ingress pump and wherein the egress line comprises a bidirectional egress pump;
- and
- maintaining a substantially constant fluid level in the organ chamber during negative pressure wet ventilation, wherein the maintaining the substantially constant fluid level comprises:
- monitoring pressure in the organ chamber using a chamber pressure sensor and a controller, wherein the chamber pressure sensor is connected to the organ chamber and configured to record and transmit a pressure reading at the organ chamber to the controller, and
- correcting for fluid shifts through the lung tissue matrix into the organ chamber by adjusting direction and duration of the bidirectional egress pump.
Dependencies are inferred from the claim text.